Latest filing published 19 Nov 2025 for Tenax Therapeutics, INC., €31k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +62.2%Entry US$7.70 · Close at T+90 US$12.50
- +77.5%Entry US$2.40 · Close at T+365 US$4.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Mcgauley: trading record in brief
Thomas Mcgauley is a declared insider at 2 companies; the most frequent names are Tenax Therapeutics, Inc. and Galectin Therapeutics Inc. We count 4 filings; the first trade dates from 24 May 2012 and the latest from 17 November 2025.
On the market, this insider has only ever bought: 4 purchases, €69k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at 3 purchases and no sales.
The median purchase comes to €16k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +62.2%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 19 November 2025: an open-market purchase of €31k, in Tenax Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Mcgauley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$7.2362.1% of flowCommon StockSEC:0001550701-25-000002:2Canonical exit: 15 Feb 2026 (T+90)
- 1,000 shares@ US$7.3512.6% of flowCommon StockSEC:0001550701-25-000002:1Canonical exit: 15 Feb 2026 (T+90)
- 2,000 shares@ US$7.337100.0% of flowCommon StockSEC:0001550701-25-000002:0Canonical exit: 15 Feb 2026 (T+90)
- 10,000 shares@ US$2.35Common StockSEC:0001181431-12-032709:0Canonical exit: 22 Aug 2012 (T+90)
4 of 4 declarations
